Munshi Amit 4

What Happened
Amit Munshi, a director of Inhibikase Therapeutics, was granted an award of 155,000 derivative securities (reported as a grant/acquisition) on June 26, 2026. The filing reports an acquisition price of $0.00 (reported value $0). The award is described in the filing as options that will vest over time per the attached footnote.

Key Details

• Transaction date: 2026-06-26; Form 4 filed: 2026-06-30. No late-filing indicator is provided in the supplied data.
• Transaction type/code: Grant/Award (A) of derivative securities.
• Quantity: 155,000 derivative shares (options). Reported acquisition price: $0.00; reported total value: $0.
• Shares owned after transaction: Not specified in the provided summary of the filing.
• Footnote (vesting): The options will vest on the earlier of June 26, 2027 or the day prior to the next annual meeting of stockholders, subject to Munshi’s continued service through such date.

Context

• This was an equity award (options) granted as compensation for board service — not an open-market purchase or sale. Such grants are common for directors and reflect compensation, not a direct market bet.
• The award vests over time; Munshi does not immediately realize tradable shares/value until vesting (and any exercise, if applicable).
• No sale or exercise was reported in this filing; there is no indication of immediate cashless exercise or disposition.